VA
MRK icon

Vident Advisory’s Merck MRK Stock Holding History

Vident Advisory’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.6M Buy
175,764
+36,440
+26% +$4.27M 0.16% 118
2026
Q1 		$16.8M Buy
139,324
+10,064
+8% +$1.16M 0.14% 126
2025
Q4 		$13.6M Buy
129,260
+9,578
+8% +$899K 0.12% 147
2025
Q3 		$10M Sell
119,682
-17,614
-13% -$1.45M 0.1% 194
2025
Q2 		$10.9M Buy
137,296
+5,318
+4% +$423K 0.12% 155
2025
Q1 		$11.8M Sell
131,978
-22,859
-15% -$2.13M 0.17% 114
2024
Q4 		$15.4M Sell
154,837
-69,345
-31% -$7.15M 0.27% 81
2024
Q3 		$25.5M Buy
224,182
+75,350
+51% +$8.95M 0.64% 25
2024
Q2 		$18.4M Buy
148,832
+3,028
+2% +$390K 0.51% 34
2024
Q1 		$19.2M Sell
145,804
-28,830
-17% -$3.55M 0.4% 61
2023
Q4 		$19M Sell
174,634
-551
-0.3% -$57.2K 0.48% 39
2023
Q3 		$18M Buy
+175,185
New +$18.9M 0.56% 31

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vident Advisory's MRK Position: Q2 2026 in Review

Vident Advisory increased its Merck (MRK) stake by 26% in Q2 2026, buying an estimated $4.27M and bringing the position to 175,764 shares worth $22.6M. The position accounts for 0.16% of the portfolio, ranked #118.

Vident Advisory first reported a position in MRK in Q3 2023 and has held it in 12 quarters since. The position peaked at $25.5M in Q3 2024. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Vident Advisory held 175,764 shares of Merck worth $22.6M as of Q2 2026.
  • Vident Advisory bought 36,440 Merck shares in Q2 2026, an estimated $4.27M.
  • Merck made up 0.16% of Vident Advisory's portfolio in Q2 2026, its #118 holding.
  • Vident Advisory first reported a position in Merck in Q3 2023 and has held it in 12 quarters since.
  • Vident Advisory's Merck position peaked at $25.5M in Q3 2024.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.